The YO Ab Screen, IFA (Immunofluorescence Assay), Serum test is a crucial diagnostic marker used primarily in neurology and oncology to detect paraneoplastic neurological syndromes, especially paraneoplastic cerebellar degeneration (PCD) associated with ovarian and breast cancers. This test identifies anti-Yo antibodies, indicative of an autoimmune response where the body's immune system mistakenly targets its own central nervous system tissues in reaction to cancer. The use of IFA, a highly sensitive technique, allows for the precise detection of these antibodies. A positive result can be an early indicator of an underlying malignancy, often before the cancer is clinically identifiable. This test is instrumental in guiding the diagnosis and management of PCD and aids in the early detection and treatment of associated cancers. The YO Ab Screen, IFA, Serum test exemplifies the intersection of neurology and oncology in modern diagnostics, emphasizing the significance of specialized testing in early cancer detection and the management of its neurological complications.
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.